As of November 6, 2026, 6 holders' latest Schedule 13D or 13G filings report owning 5% or more of Immatics N.V. The largest reported stake is T. Rowe Price Investment Management, Inc.'s, at 16.1%. 14 filings are on record since August 12, 2025 (Schedule 13G/A, May 15, 2026).
Sell to companies like Immatics N.V? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Perceptive Advisors LLC · Sole voting: 0 · Shared voting: 11,418,016 · Sole dispositive: 0 · Shared dispositive: 11,418,016 · SCHEDULE 13D/A, 2026-08-27
- · Reporting person: Baker Bros. Advisors LP · Sole voting: 9,508,565 · Shared voting: 0 · Sole dispositive: 9,508,565 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-08-14
- · Holder: Vestal Point Capital, LP · Percent: 4.6% · SCHEDULE 13G/A
- · Holder: The Toronto-Dominion Bank · Percent: 5.5% · SCHEDULE 13G
- · Holder: RTW Investments, LP · Percent: 9.6% · SCHEDULE 13G/A
Immatics N.V. has 14 Schedule 13D or 13G filings on record since 2025-08-12. 6 holders' latest filing reports 5% or more of ordinary shares, nominal value eur 0.01 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 16.1% | 21,652,162 | SCHEDULE 13G/A, 2026-05-15 | 2026-03-31 |
| RTW Investments, LP | 9.6% | 12,869,340 | SCHEDULE 13G/A, 2026-05-15 | 2026-03-31 |
| Suvretta Capital Management, LLC | 8.3% | 11,190,129 | SCHEDULE 13G/A, 2026-02-13 | 2025-12-31 |
| Perceptive Advisors LLC | 7.6% | 11,418,016 | SCHEDULE 13D/A, 2026-08-27 | 2026-08-26 |
| Baker Bros. Advisors LP | 7% | 9,508,565 | SCHEDULE 13G/A, 2026-08-14 | 2026-06-30 |
| The Toronto-Dominion Bank | 5.5% | 7,436,342 | SCHEDULE 13G, 2026-05-15 | 2026-03-31 |
| Vestal Point Capital, LP | 4.6% | 6,175,000 | SCHEDULE 13G/A, 2026-05-15 | 2026-03-31 |
| Wellington Management Group LLP | 4.4% | 5,318,624 | SCHEDULE 13G/A, 2025-08-12 | 2025-06-30 |
Holding shares or following this stake? See who's behind Immatics N.V. and the warning signs.
Free to see. No signup.
Keep reading
More on Immatics N.V. and the records around it.
Immatics N.V. elsewhere on the record
Companies that share a holder
- The Toronto-Dominion Bank also filed stake reports on 5 other companies: eBay Inc. (Aug 2026), Stoke Therapeutics, Inc. (Aug 2026), UroGen Pharma Ltd. (Aug 2026)
- Suvretta Capital Management, LLC also filed stake reports on 22 other companies: Veradermics, Inc (Aug 2026), Abeona Therapeutics Inc. (Aug 2026), Fulcrum Therapeutics, Inc. (Aug 2026)
- Baker Bros. Advisors LP also filed stake reports on 25 other companies: Madrigal Pharmaceuticals, Inc. (Nov 2026), Kodiak Sciences Inc. (Sep 2026), BeOne Medicines Ltd. (Sep 2026)
Watch Immatics N.V.
Get an email when Immatics N.V. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Immatics N.V.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Immatics N.V.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Immatics N.V. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
14 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 0 | 11,418,016 | 0 | 11,418,016 | SCHEDULE 13D/A, 2026-08-27 |
| Perceptive Life Sciences Master Fund, Ltd. | 0 | 11,418,016 | 0 | 11,418,016 | SCHEDULE 13D/A, 2026-08-27 |
| Joseph Edelman | 0 | 11,418,016 | 0 | 11,418,016 | SCHEDULE 13D/A, 2026-08-27 |
| Baker Bros. Advisors LP | 9,508,565 | 0 | 9,508,565 | 0 | SCHEDULE 13G/A, 2026-08-14 |
| Baker Bros. Advisors (GP) LLC | 9,508,565 | 0 | 9,508,565 | 0 | SCHEDULE 13G/A, 2026-08-14 |
| Julian C. Baker | 9,508,565 | 0 | 9,508,565 | 0 | SCHEDULE 13G/A, 2026-08-14 |
| Felix J. Baker | 9,508,565 | 0 | 9,508,565 | 0 | SCHEDULE 13G/A, 2026-08-14 |
The latest filing identifies Immatics N.V. by CUSIP N44445109 and gives its principal executive office as PAUL EHRLICH-STRASSE 15, TUBINGEN (SCHEDULE 13D/A, 2026-08-27).
What the percentages are based on
The information in Item 11 of each of the cover pages to this Amendment No. 6 is incorporated herein by reference. The percentage of beneficial ownership for each of the Reporting Persons reported herein is based on 136,673,161 shares of Common Stock outstanding as of March 31, 2026, as reported in the Issuer's 6-K filed with the Securities and Exchange Commission ("SEC") on May 12, 2026.Baker Bros. Advisors LP, SCHEDULE 13G/A, 2026-08-14
Source of funds (Item 3)
The shares of Ordinary Shares set forth below in Item 5(c) of this Amendment No. 2 to Schedule 13D were acquired with working capital of Perceptive Life Sciences Master Fund, Ltd. (the "Master Fund").Perceptive Advisors LLC, SCHEDULE 13D/A, 2026-08-27
Purpose of Transaction (Item 4)
Perceptive Advisors LLC
The information set forth in Item 6 below in this Amendment No. 2 to Schedule 13D is incorporated by reference.Item 4 of the SCHEDULE 13D/A filed 2026-08-27
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-12 | Wellington Management Group LLP | 4.4% | SCHEDULE 13G/A |
| 2025-08-13 | Suvretta Capital Management, LLC | 9.9% | SCHEDULE 13G/A |
| 2025-08-14 | Baker Bros. Advisors LP | 8.4% | SCHEDULE 13G/A |
| 2025-08-14 | T. Rowe Price Investment Management, Inc. | 15.1% | SCHEDULE 13G/A |
| 2025-11-14 | Baker Bros. Advisors LP | 9.95% | SCHEDULE 13G/A |
| 2025-11-14 | RTW Investments, LP | 7.3% | SCHEDULE 13G/A |
| 2026-02-13 | Suvretta Capital Management, LLC | 8.3% | SCHEDULE 13G/A |
| 2026-02-17 | RTW Investments, LP | 8.5% | SCHEDULE 13G/A |
| 2026-05-15 | Vestal Point Capital, LP | 4.6% | SCHEDULE 13G/A |
| 2026-05-15 | The Toronto-Dominion Bank | 5.5% | SCHEDULE 13G |
| 2026-05-15 | RTW Investments, LP | 9.6% | SCHEDULE 13G/A |
| 2026-05-15 | T. Rowe Price Investment Management, Inc. | 16.1% | SCHEDULE 13G/A |
| 2026-08-14 | Baker Bros. Advisors LP | 7% | SCHEDULE 13G/A |
| 2026-08-27 | Perceptive Advisors LLC | 7.6% | SCHEDULE 13D/A |
Questions about who owns Immatics N.V.
Who owns Immatics N.V.?
On this page, 6 holders' latest ownership filings report 5% or more of Immatics N.V.: T. Rowe Price Investment Management, Inc. (16.1%, Schedule 13G/A, filed 2026-05-15), RTW Investments, LP (9.6%, Schedule 13G/A, filed 2026-05-15), Suvretta Capital Management, LLC (8.3%, Schedule 13G/A, filed 2026-02-13), Perceptive Advisors LLC (7.6%, Schedule 13D/A, filed 2026-08-27) and Baker Bros. Advisors LP (7%, Schedule 13G/A, filed 2026-08-14); 1 more is listed above.
Who are the largest shareholders of Immatics N.V.?
By the share each holder's latest filing reports, the largest holders of Immatics N.V. on this page are T. Rowe Price Investment Management, Inc. (16.1%), RTW Investments, LP (9.6%) and Suvretta Capital Management, LLC (8.3%).
When did T. Rowe Price Investment Management, Inc. buy into Immatics N.V.?
The filings give report dates, not purchase dates. The earliest filing from T. Rowe Price Investment Management, Inc. on this page is the Schedule 13G/A, filed 2025-08-14, reporting 15.1%; its latest, Schedule 13G/A filed 2026-05-15, reports 16.1%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 14 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Tools for this story
Each opens in a new tab, filled in for Immatics N.V.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.